API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
50
PharmaCompass offers a list of Rivastigmine Tartrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Rivastigmine Tartrate manufacturer or Rivastigmine Tartrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rivastigmine Tartrate manufacturer or Rivastigmine Tartrate supplier.
PharmaCompass also assists you with knowing the Rivastigmine Tartrate API Price utilized in the formulation of products. Rivastigmine Tartrate API Price is not always fixed or binding as the Rivastigmine Tartrate Price is obtained through a variety of data sources. The Rivastigmine Tartrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Rivastigmine Tartrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rivastigmine Tartrate, including repackagers and relabelers. The FDA regulates Rivastigmine Tartrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rivastigmine Tartrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Rivastigmine Tartrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Rivastigmine Tartrate supplier is an individual or a company that provides Rivastigmine Tartrate active pharmaceutical ingredient (API) or Rivastigmine Tartrate finished formulations upon request. The Rivastigmine Tartrate suppliers may include Rivastigmine Tartrate API manufacturers, exporters, distributors and traders.
click here to find a list of Rivastigmine Tartrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Rivastigmine Tartrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Rivastigmine Tartrate active pharmaceutical ingredient (API) in detail. Different forms of Rivastigmine Tartrate DMFs exist exist since differing nations have different regulations, such as Rivastigmine Tartrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Rivastigmine Tartrate DMF submitted to regulatory agencies in the US is known as a USDMF. Rivastigmine Tartrate USDMF includes data on Rivastigmine Tartrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Rivastigmine Tartrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Rivastigmine Tartrate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Rivastigmine Tartrate Drug Master File in Korea (Rivastigmine Tartrate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Rivastigmine Tartrate. The MFDS reviews the Rivastigmine Tartrate KDMF as part of the drug registration process and uses the information provided in the Rivastigmine Tartrate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Rivastigmine Tartrate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Rivastigmine Tartrate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Rivastigmine Tartrate suppliers with KDMF on PharmaCompass.
A Rivastigmine Tartrate CEP of the European Pharmacopoeia monograph is often referred to as a Rivastigmine Tartrate Certificate of Suitability (COS). The purpose of a Rivastigmine Tartrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Rivastigmine Tartrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Rivastigmine Tartrate to their clients by showing that a Rivastigmine Tartrate CEP has been issued for it. The manufacturer submits a Rivastigmine Tartrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Rivastigmine Tartrate CEP holder for the record. Additionally, the data presented in the Rivastigmine Tartrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Rivastigmine Tartrate DMF.
A Rivastigmine Tartrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Rivastigmine Tartrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Rivastigmine Tartrate suppliers with CEP (COS) on PharmaCompass.
A Rivastigmine Tartrate written confirmation (Rivastigmine Tartrate WC) is an official document issued by a regulatory agency to a Rivastigmine Tartrate manufacturer, verifying that the manufacturing facility of a Rivastigmine Tartrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Rivastigmine Tartrate APIs or Rivastigmine Tartrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Rivastigmine Tartrate WC (written confirmation) as part of the regulatory process.
click here to find a list of Rivastigmine Tartrate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Rivastigmine Tartrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Rivastigmine Tartrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Rivastigmine Tartrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Rivastigmine Tartrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Rivastigmine Tartrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Rivastigmine Tartrate suppliers with NDC on PharmaCompass.
Rivastigmine Tartrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Rivastigmine Tartrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Rivastigmine Tartrate GMP manufacturer or Rivastigmine Tartrate GMP API supplier for your needs.
A Rivastigmine Tartrate CoA (Certificate of Analysis) is a formal document that attests to Rivastigmine Tartrate's compliance with Rivastigmine Tartrate specifications and serves as a tool for batch-level quality control.
Rivastigmine Tartrate CoA mostly includes findings from lab analyses of a specific batch. For each Rivastigmine Tartrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Rivastigmine Tartrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Rivastigmine Tartrate EP), Rivastigmine Tartrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rivastigmine Tartrate USP).